Grantham, Mayo, Van Otterloo & Co (GMO)
FLGT icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Fulgent Genetics FLGT Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,100
Closed -$301K – 726
2022
Q4 		$301K Buy
+10,100
New +$361K ﹤0.01% 633

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s FLGT Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Fulgent Genetics (FLGT) in Q1 2023, closing a stake of 10,100 shares — an estimated $301K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in FLGT in Q4 2022 and held it in 1 quarter. The position peaked at $301K in Q4 2022. 215 funds tracked by Wall St. Rank hold FLGT as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Fulgent Genetics position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 10,100 Fulgent Genetics shares in Q1 2023, an estimated $301K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Fulgent Genetics in Q4 2022 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Fulgent Genetics position peaked at $301K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.